Neurology (Medicine) papers
Pofolia’s corpus holds 89 papers from Neurology (Medicine) (1992–2026), each with a short summary. Below, the 20 most-cited, then the most recently added.
At a glance
- Most cited: Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. (1992, 10,472 citations).
- The 20 papers listed have 86,604 citations between them.
- 19 of the 19 with a known journal quartile appeared in a Q1 journal.
- 11 have a free full text (open access).
- Most frequent journals: JAMA, Movement Disorders, Stroke.
- Published between 1992 and 2021.
Most cited
Ranked by citation count. Because citations accumulate over time, this list naturally leans towards work published a few years ago; for where the field is now, see “recently added”. How to read the signals
Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.
Journal of Neurology Neurosurgery & Psychiatry · 1992 · Q1 · SJR 2.00 · FWCI 34.41 · 10,472 citations · Open access
A clinico-pathological study of 100 Parkinson's disease diagnoses found that only 76% were accurate, with misdiagnoses including progressive supranuclear palsy and multiple system atrophy. Applying stricter diagnostic criteria retrospectively improved accuracy to 82%.
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
JAMA Internal Medicine · 2020 · Q1 · SJR 4.00 · FWCI 674.42 · 8,755 citations
In COVID-19 pneumonia patients, older age, neutrophilia, and organ/coagulation dysfunction significantly increased the risk of developing ARDS and progressing to death. High fever (≥39°C) paradoxically predicted higher ARDS risk but lower mortality.
MDS clinical diagnostic criteria for Parkinson's disease
Movement Disorders · 2015 · Q1 · SJR 2.00 · FWCI 121.59 · 7,490 citations · Open access
The Movement Disorder Society (MDS) has introduced new clinical diagnostic criteria for Parkinson's disease (PD) to standardize diagnosis in research and clinical settings.
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China
JAMA Neurology · 2020 · Q1 · SJR 5.00 · FWCI 571.66 · 7,404 citations · Open access
Over a third of hospitalized COVID-19 patients in Wuhan (36.4%) experienced neurological symptoms, with severe cases showing significantly higher rates of cerebrovascular events, impaired consciousness, and muscle injury.
Persistent Symptoms in Patients After Acute COVID-19
JAMA · 2020 · Q1 · SJR 5.00 · FWCI 324.65 · 4,778 citations · Open access
The COVID-19 death rate in US prisons was 39 per 100,000, higher than the general US population rate of 29 per 100,000.
Diagnosis and management of dementia with Lewy bodies
Neurology · 2017 · Q1 · SJR 2.00 · FWCI 189.55 · 4,475 citations · Open access
The DLB Consortium has updated its diagnostic criteria for Dementia with Lewy Bodies, distinguishing clinical features from biomarkers and increasing the diagnostic weight of REM sleep behavior disorder and MIBG myocardial scintigraphy.
Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis
International Journal of Infectious Diseases · 2020 · Q1 · SJR 1.00 · FWCI 127.18 · 4,445 citations · Open access
This meta-analysis of seven studies involving 1,576 COVID-19 patients found hypertension (21.1%) and diabetes (9.7%) were the most common comorbidities. Patients with hypertension, respiratory disease, or cardiovascular disease were significantly more likely to develop severe COVID-19.
Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition
Neurosurgery · 2016 · Q1 · SJR 1.00 · FWCI 220.85 · 4,313 citations
This fourth edition guideline synthesizes evidence to provide recommendations for managing severe traumatic brain injury, clarifying which aspects of care are supported by current evidence.
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
Stroke · 2015 · Q1 · SJR 2.00 · FWCI 225.27 · 3,996 citations
This guideline provides comprehensive, evidence-based recommendations for the diagnosis and treatment of spontaneous intracerebral hemorrhage, incorporating new phase 3 trial results.
Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage
Stroke · 2012 · Q1 · SJR 2.00 · FWCI 109.78 · 3,518 citations · Open access
This guideline provides comprehensive, evidence-based recommendations for the diagnosis and treatment of aneurysmal subarachnoid hemorrhage (aSAH), aiming to improve patient outcomes through aggressive, expert care.
Characterizing long COVID in an international cohort: 7 months of symptoms and their impact
EClinicalMedicine · 2021 · Q1 · SJR 4.00 · FWCI 236.21 · 3,004 citations · Open access
A global survey of over 3700 individuals found that most Long COVID patients (over 91%) exceeded 35 weeks to recovery, experiencing an average of 56 symptoms across 9 organ systems, with fatigue, post-exertional malaise, and cognitive dysfunction being most frequent after 6 months.
Diagnosis and Treatment of Parkinson Disease
JAMA · 2020 · Q1 · SJR 5.00 · FWCI 116.06 · 2,853 citations
Parkinson disease is a heterogeneous neurological disorder affecting over 6 million people globally, characterized by motor symptoms like tremor and slowness, and often accompanied by non-motor issues. Diagnosis relies on clinical history and examination, with imaging aiding uncertain cases.
Green's Operative Hand Surgery
2016 · FWCI 94.71 · 2,798 citations
This entry refers to the comprehensive reference work 'Green's Operative Hand Surgery'.
Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
The Lancet Neurology · 2018 · Q1 · SJR 12.00 · FWCI 128.86 · 2,791 citations · Open access
The global burden of Parkinson's disease more than doubled between 1990 and 2016, with 6.1 million people affected in 2016, a significant increase driven by both an aging population and a 21.7% rise in age-standardized prevalence rates.
Neurologic Features in Severe SARS-CoV-2 Infection
New England Journal of Medicine · 2020 · Q1 · SJR 18.00 · FWCI 219.60 · 2,788 citations
In a series of 64 patients with severe COVID-19 and ARDS, 58 underwent neurologic examination, revealing significant rates of severe agitation and corticospinal signs.
Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
Science · 2012 · Q1 · SJR 10.00 · FWCI 76.84 · 2,610 citations
Researchers demonstrated that injecting synthetic misfolded α-synuclein fibrils into healthy mice can initiate Parkinson's-like pathology, including Lewy body formation and dopaminergic neuron loss, leading to motor deficits.
Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies
The Lancet Neurology · 2019 · Q1 · SJR 12.00 · FWCI 60.88 · 2,561 citations
This meta-analysis of Parkinson's disease genome-wide association studies identified numerous new genetic risk factors and provided a comprehensive overview of heritable risk.
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines
Movement Disorders · 2012 · Q1 · SJR 2.00 · FWCI 69.81 · 2,541 citations
The Movement Disorder Society has established new diagnostic criteria for mild cognitive impairment (MCI) in Parkinson's disease (PD) patients, based on a literature review and expert consensus.
Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic
The Lancet Psychiatry · 2020 · Q1 · SJR 8.00 · FWCI 67.29 · 2,511 citations · Open access
Severe coronavirus infections like SARS, MERS, and COVID-19 are linked to significant psychiatric and neuropsychiatric issues, both during acute illness and in the long term.
More than 50 long-term effects of COVID-19: a systematic review and meta-analysis
Scientific Reports · 2021 · Q1 · FWCI 99.83 · 2,501 citations · Open access
A meta-analysis of 15 studies including 47,910 patients found that 80% of COVID-19 survivors experience at least one long-term symptom, with fatigue being the most common.
Recently added
Mismatch between quality and engagement in myasthenia gravis–related videos: a cross-sectional study on Chinese social media platforms
Scientific Reports · 2026 · Q1
Myasthenia gravis (MG) videos on Chinese platforms Douyin and Red Note show moderate quality, with physicians as primary creators, yet user engagement (likes, shares) weakly correlates with informational quality (JAMA, GQS, mDISCERN scores).
Sex-specific patterns of symptom burden, psychological distress, and work productivity impairment in post-acute sequelae of COVID-19: a 10-month dynamic cohort study
BMC Pulmonary Medicine · 2026 · Q2
Females with post-acute sequelae of COVID-19 (PASC) reported significantly higher fatigue, anxiety, lower quality of life, and greater work productivity impairment compared to males over 10 months, even after adjusting for baseline differences.
Multidimensional analysis on the potential of cell cycle-related gene STMN1 as a tumor biomarker
Discover Oncology · 2026 · Q2
STMN1, a gene regulating cell division, is significantly overexpressed in most cancers, linked to advanced stages, and predicts poor survival in eight cancer types, according to a pan-cancer analysis using multi-omics data.
Species-dependent activities of the PINK1–parkin axis
Translational Neurodegeneration · 2026 · Q1 · SJR 4.00
Knocking down PINK1 or parkin in non-human primates, but not mice or pigs, causes dopaminergic neuron loss and alpha-synuclein pathology, indicating species-dependent differences in the PINK1-parkin axis contribute to Parkinson's disease.
Short-Term Effects of Radial Extracorporeal Shock Wave Therapy in Addition to Physiotherapy on Spasticity, Walking Performance, and Quality of Life in Chronic Stroke: A Sham-Controlled Randomized Trial
Neurorehabilitation · 2026 · Q2
Adding radial extracorporeal shock wave therapy (rESWT) to physiotherapy for 4 weeks significantly improved spasticity (MAS -0.56), walking speed (10MWT -1.41s), functional mobility (TUG -2.46s), motor function (FMA-LE 4.42), and quality of life (SS-QOL 11.73) in chronic stroke patients.
Metabolomic-microbiomic integrated analysis reveals the role of intermittent energy restriction in Parkinson’s disease
Neurodegenerative Disease Management · 2026 · Q2
Intermittent energy restriction (IER) delays Parkinson's disease (PD) progression in mice by altering gut microbiota and metabolites, decreasing key proteins Parkin and HIF-1α in both gut and brain tissues.
Patient-reported outcomes after surgical treatment of spontaneous intracranial hypotension: a cross-sectional study
Acta Neurologica Belgica · 2026 · Q2
15.2% of surgically treated spontaneous intracranial hypotension (SIH) patients reported complete symptom resolution, with a substantial proportion experiencing persistent symptoms, rebound intracranial hypertension, headache disability (mean HIT-6 score 56.75), and psychosocial burden.
HIPK2 loss promotes TDP-43 cytoplasmic mis-localization through MAPK-pathway and is associated with TDP-43 proteinopathy in vivo
Cell Death and Disease · 2026 · Q1 · SJR 3.00
Loss of HIPK2 kinase in neurons causes the protein TDP-43 to mis-localize to the cytoplasm, a key feature of neurodegenerative diseases like ALS, by activating the MAPK pathway.
Journals in this field
The journals that publish most of this field’s papers. Quartile (Q1–Q4), SJR and h-index are from SCImago Journal Rank; “in this field” is how many of the journal’s pooled papers belong here. What is a Q1 journal? · What is the h-index?
| Journal | Quartile | SJR | h-index | In this field | Summaries |
|---|---|---|---|---|---|
| New England Journal of Medicine | Q1 | 18.00 | 1275 | 7 | 376 |
| Movement Disorders | Q1 | 2.00 | 247 | 6 | 8 |
| The Lancet Neurology | Q1 | 12.00 | 398 | 4 | 12 |
| The Lancet Psychiatry | Q1 | 8.00 | 176 | 3 | 6 |
| JAMA | Q1 | 5.00 | 818 | 3 | 114 |
| Neurology | Q1 | 2.00 | 435 | 3 | 12 |
| Stroke | Q1 | 2.00 | 382 | 3 | 15 |
| Neurosurgery | Q1 | 1.00 | 236 | 3 | 5 |
Every journal in Neurology (Medicine) (Q1–Q4) →
Add this field to your daily feed
Pick your interests and new work in your area arrives every day, summarised. Full summaries live in the app.
Open the app